VCAN Polyclonal Antibody
Conditions of optimal VCAN polyclonal antibody performance should be determined experimentally by the investigator.
- 产品描述
- 描述
- More Offers
货号 | PA003692-PA1755 |
---|---|
产品名称 | VCAN Polyclonal Antibody |
供货商名称 | Syd Labs, Inc. |
品牌名 | 悉得(Syd Labs) |
别称 | Versican core protein ,Large fibroblast proteoglycan; Chondroitin sulfate proteoglycan core protein 2 |
同种型 | Rabbit IgG. |
反应性 | Human, Rat, Mouse. |
免疫源 | A synthetic peptide corresponding to a sequence at the C-terminal of human versican, identical to the related rat and mouse sequences. |
纯化 | Immunogen affinity purified. |
抗体形式 | Lyophilized. |
稳定性与存储 | Stable for 1 year at -20°C and 3 months at 4°C. For maximum recovery of the product, centrifuge the original vial after thawing and before removing the cap. Aliquot to avoid repeated freezing and thawing. |
注意事项 | Conditions of optimal VCAN antibody performance should be determined experimentally by the investigator. |
线下下单 | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
描述
PA003692-PA1755: VCAN Polyclonal Antibody
Introduction
Versican(VCAN),also known as CSPG2, is a large extracellular matrix proteoglycan that is present in a variety of human tissues. Versican is a large chondroitin sulfate proteoglycan with an apparent molecular mass of more than 1000kDa.The Versican gene is mapped on 5q14.2-q14.3. The human versican gene contains 15 exons spanning more than 90 kb. The distribution of versican by using affinity-purified polyclonal antibodies that recognize the core protein of the prominent versican splice variants V0 and V1. Versican staining was noted in the central and peripheral nervous system, in the basal layer of the epidermis, and on the luminal surface of some glandular epithelia. Biochemical purification of LLC-conditioned medium led to identification of the extracellular matrix proteoglycan versican, which is upregulated in many human tumors including lung cancer, as a macrophage activator that acts through TLR2 and its coreceptors TLR6 and CD14. By activating TLR2:TLR6 complexes and inducing TNF-alpha secretion by myeloid cells, versican strongly enhances LLC metastatic growth.
Other VCAN Antibody:
VCAN Polyclonal Antibody